Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology.
Angiotensin I-converting enzyme (ACE) plays a pivotal role in cardiovascular homeostasis and by activating angiotensin I into angiotensin II and inactivating bradykinin. These two peptides play antagonistic roles on the cardiovascular system by regulating vascular tone and vascular smooth muscle cell proliferation. Identification of the ACE gene as a genetic marker for various forms of cardiovascular disease is a recent result of the progress made in molecular biology and genetics. The insertion/deletion (ID) polymorphism of the ACE gene defined by the presence or absence of the 287 base pair Alu sequence situated in intron 16 has been investigated as a possible genetic marker for a variety of cardiovascular disease including myocardial infarction, essential hypertension, cardiomyopathy, and diabetic vascular complications. This paper reviews prior reports and briefly describes our recent study on the association of the ACE I/D polymorphism and antiproteinuric effect of ACE inhibitors in patients with proteinuria.
Kitamura
H
H
First Department of Medicine, Osaka University School of Medicine, Japan.
Moriyama
T
T
Izumi
M
M
Yokoyama
K
K
Yamauchi
A
A
Ueda
N
N
Kamada
T
T
Imai
E
E
D002318:Cardiovascular Diseases / Q000235:genetics* / Q000503:physiopathology; D005819:Genetic Markers; D006801:Humans; D007674:Kidney Diseases / Q000235:genetics* / Q000503:physiopathology; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*
D005819:Genetic Markers; D007703:Peptidyl-Dipeptidase A